Invention Grant
US08647622B2 Humanized anti-CXCR5 antibodies, derivatives thereof and their use
有权
人源化抗CXCR5抗体及其衍生物及其用途
- Patent Title: Humanized anti-CXCR5 antibodies, derivatives thereof and their use
- Patent Title (中): 人源化抗CXCR5抗体及其衍生物及其用途
-
Application No.: US12675799Application Date: 2008-08-27
-
Publication No.: US08647622B2Publication Date: 2014-02-11
- Inventor: Renata Lee , Vincent Mikol , Elizabeth Allen , Norman Ruetsch , Beatrice Cameron , Thomas Oligino , Nicolas Baurin
- Applicant: Renata Lee , Vincent Mikol , Elizabeth Allen , Norman Ruetsch , Beatrice Cameron , Thomas Oligino , Nicolas Baurin
- Applicant Address: FR Paris
- Assignee: Sanofi
- Current Assignee: Sanofi
- Current Assignee Address: FR Paris
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Agent J. Darrell Fontenot; Ann Marie Szczepanik
- International Application: PCT/US2008/074381 WO 20080827
- International Announcement: WO2009/032661 WO 20090312
- Main IPC: A61K39/395
- IPC: A61K39/395
Abstract:
The present invention relates to humanized antibodies that specifically bind to CXCR5 and can, for example, inhibit CXCR5 function. The invention also includes uses of the antibodies to treat or prevent CXCR5 related diseases or disorders.
Public/Granted literature
- US20110027266A1 Humanized anti-CXCR5 antibodies, derivatives thereof and their use Public/Granted day:2011-02-03
Information query
